20 Apr 2026
Ruxolitinib attenuates diethylnitrosamine-induced liver injury in mice: involvement of TLR4/MYD88/NF-κB and IL-6/JAK/STAT pathwaysPublisher siteNaunyn-Schmiedeberg s Archives of Pharmacology, Drug-Induced Hepatotoxicity and Protection
UniversitiesSara H. Hazem
Active, last published 2026
Sara H.
Hazem
Scholar“Research profile drawn from open scholarly records.”
Mansoura University
Claim Your Profile3
H-index
61
Citations
Sara has not officially claimed their profile. If you are Sara, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
research summary for Sara H. Hazem will appear here once their profile is updated.
02 · Reach
Publication output and reach
Sara's work has been cited 61 times across 3 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
04 · Where I am
Affiliations
Affiliation on published researchMansoura UniversityDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
9 works1 Feb 2026
Modulatory Effects of Chrysin on Cadmium‐Induced Hepatotoxicity and Testicular Injury in RatsPublisher siteJournal of Biochemical and Molecular Toxicology, Heavy Metal Exposure and Toxicity
13 Mar 2024Open access
Corrigendum: Unveiling the therapeutic potential of exogenous β-hydroxybutyrate for chronic colitis in rats: novel insights on autophagy, apoptosis, and pyroptosisPublisher siteFrontiers in Pharmacology, Metabolism and Genetic Disorders
28 Sept 2023Open access40cites
Unveiling the therapeutic potential of exogenous β-hydroxybutyrate for chronic colitis in rats: novel insights on autophagy, apoptosis, and pyroptosisPublisher siteFrontiers in Pharmacology, Diet and metabolism studies
5 Sept 2023Open access1cites
Corrigendum: Mitigation of acetaminophen-induced liver toxicity by the novel phosphatidylinositol 3-kinase inhibitor alpelisibPublisher siteFrontiers in Pharmacology, Drug-Induced Hepatotoxicity and Protection
7 Aug 2023Open access2cites
Mitigation of acetaminophen-induced liver toxicity by the novel phosphatidylinositol 3-kinase inhibitor alpelisibPublisher siteFrontiers in Pharmacology, Drug-Induced Hepatotoxicity and Protection
28 Jul 2023Open access13cites
STA9090 as a Potential Therapeutic Agent for Liver Fibrosis by Modulating the HSP90/TβRII/Proteasome Interplay: Novel Insights from In Vitro and In Vivo InvestigationsPublisher sitePharmaceuticals, Liver physiology and pathology
11 Jul 20232cites
WITHDRAWN: Vinpocetine and Lactobacillus improve fatty liver in rats via modulating the oxidative stress, inflammation, adiponectin and gut microbiomePublisher siteLife Sciences, Liver Disease Diagnosis and Treatment
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Sara?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you